Completing data — refresh the page later to see the latest
1364933-59-4CCCCCn1cc(C(=O)c2ccc(F)c3ccccc23)c2ccccc21HDWMKVHXWFNFQW-UHFFFAOYSA-N(4-fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone is a DEA Schedule I controlled substance. Substances in the DEA Schedule I have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. It is a Cannabimimetic agents substance.
1364933-59-4DTXSID101010001CHEMBL2206855Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
DescriptionJWH 412 is a positional isomer of AM2201 that was identified in the ‘herbal mixture’ XoXo. The substitution of hydrogen against fluorine in the 4-position of the naphthyl moiety enhances the binding affinity to the central cannabinoid (CB1) receptor compared to the unsubstituted JWH 018. JWH 412 demonstrates Ki values of 7.2 and 3.2 nM at CB1 and peripheral CB2 receptors, respectively. This product is intended for research and forensic purposes.
UsesJWH 412 is a naphthoylindoles acting on cannabinoid receptors identified based on their fragmentation patterns under ESI-QTOFMS.
UsesJWH 412 is a positional isomer of AM2201 that was identified in the ‘herbal mixture’ XoXo. The substitution of hydrogen against fluorine in the 4-position of the naphthyl moiety enhances the binding affinity to the central cannabinoid (CB1) receptor compared to the unsubstituted JWH 018. JWH 412 demonstrates Ki values of 7.2 and 3.2 nM at CB1 and peripheral CB2 receptors, respectively. This product is intended for research and forensic purposes.[Cayman Chemical]